NCT01465971

Brief Summary

One of the major challenges in adapting to high altitudes is that with increasing altitude sleeping quality declines rapidly. Thus, the night sleep can only provide limited to none regeneration. It usually takes a prolonged stay at a constant altitude to adapt sufficiently to the altitude and to have a refreshing night sleep. 1975 Reit et. al showed in their EEG-recordings that the sleep architecture (the regular succession of the particular sleep phases) is disturbed by repeating arousals which occur due to an irregularity in the breathing rhythm. The purpose of this study is to create a better understanding of the underlying mechanisms that lead to failed acclimatization and AMS, due to sleep disturbance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2011

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 7, 2011

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

April 6, 2012

Status Verified

April 1, 2012

Enrollment Period

7 months

First QC Date

October 26, 2011

Last Update Submit

April 4, 2012

Conditions

Keywords

highaltitudeacutemountainsicknesssleepdisorderperiodicbreathinghyperventilationapnea

Outcome Measures

Primary Outcomes (1)

  • Tissue oxygenation index

    Measured with near infra-red spectroscopy

    participants will be followed for the duration of the expedition, an expected 7 days

Secondary Outcomes (1)

  • Tissue hemoglobin index

    participants will be followed for the duration of the expedition, an expected 7 days

Study Arms (2)

not acclimatized

no stay in an altitude above 2500 m within the last 3 Months

acclimatized

stay above 2500 m with the last 14 days

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

participants of an expedition to Mount Kilimanjaro

You may qualify if:

  • Age: 18 - 80 years
  • voluntary participation in an expedition to Mount Kilimanjaro

You may not qualify if:

  • obstructive or restrictive respiratory disorder
  • hemodynamic relevant cardiac defect
  • sleep disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic for Anaesthesia, Intensive Care Medicine and Pain Therapy

Frankfurt am Main, Hesse, 60318, Germany

Location

Related Publications (2)

  • Jackson SJ, Varley J, Sellers C, Josephs K, Codrington L, Duke G, Njelekela MA, Drummond G, Sutherland AI, Thompson AA, Baillie JK. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro. High Alt Med Biol. 2010 Fall;11(3):217-22. doi: 10.1089/ham.2010.1003.

    PMID: 20919888BACKGROUND
  • Szymczak RK, Sitek EJ, Slawek JW, Basinski A, Sieminski M, Wieczorek D. Subjective sleep quality alterations at high altitude. Wilderness Environ Med. 2009 Winter;20(4):305-10. doi: 10.1580/1080-6032-020.004.0305.

    PMID: 20030436BACKGROUND

Related Links

MeSH Terms

Conditions

DyssomniasCheyne-Stokes RespirationAltitude SicknessDiseaseRespiratory AspirationHyperventilationApnea

Condition Hierarchy (Ancestors)

Sleep Wake DisordersNervous System DiseasesMental DisordersRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Peter Stein, Dr.med.

    Goethe University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant of the Department for Anesthesiology, Intensive Care Medicine and Pain Therapy of the Goethe-University Frankfurt / Germany - Head of the working group for expedition medicine

Study Record Dates

First Submitted

October 26, 2011

First Posted

November 7, 2011

Study Start

May 1, 2011

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

April 6, 2012

Record last verified: 2012-04

Locations